Cargando…

Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios

AIM: To describe a 3 years experience of peripheral arterial embolization with Micro Vascular Plug (MVP) (Medtronic, USA). MATERIALS AND METHODS: The following parameters were investigated: type of vascular injury, anticoagulation therapy at time of procedure, anatomical district, caliper of the tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Giurazza, Francesco, Ierardi, Anna Maria, Contegiacomo, Andrea, Corvino, Fabio, Carrafiello, Giampaolo, Niola, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273051/
https://www.ncbi.nlm.nih.gov/pubmed/34250548
http://dx.doi.org/10.1186/s42155-021-00246-2
_version_ 1783721305466470400
author Giurazza, Francesco
Ierardi, Anna Maria
Contegiacomo, Andrea
Corvino, Fabio
Carrafiello, Giampaolo
Niola, Raffaella
author_facet Giurazza, Francesco
Ierardi, Anna Maria
Contegiacomo, Andrea
Corvino, Fabio
Carrafiello, Giampaolo
Niola, Raffaella
author_sort Giurazza, Francesco
collection PubMed
description AIM: To describe a 3 years experience of peripheral arterial embolization with Micro Vascular Plug (MVP) (Medtronic, USA). MATERIALS AND METHODS: The following parameters were investigated: type of vascular injury, anticoagulation therapy at time of procedure, anatomical district, caliper of the target artery, course of the landing zone, additional embolics, technical and clinical success, device related clinical complications. Technical success was defined as complete embolization without deployment of additional embolics after MVP release. Primary clinical success was considered as hemodynamic stability in emergency setting and resolution of the underlying vascular pathology in elective cases; secondary clinical success was considered clinical success after a second embolization session. RESULTS: 116 MVP have been released in 104 patients (67 males and 37 females; mean age 61.3 years). The pullback release technique was adopted in each case. 85 patients were treated in emergent settings while in 19 patients the procedure was scheduled. The overall technical success was 75%. Primary clinical success was 96.1%, secondary clinical success 3% and clinical failure 0.9%. No statistical differences in terms of effectiveness were observed among patients assuming anticoagulation (p-value = 0.6). A straight and longer landing zone were statistically associated with higher technical success compared to curved and shorter ones, (p-values < 0.001 and = 0.048 respectively). MVP-3 and MVP-5 were the most frequently adopted models in this sample, in 29.8% and 49% of the patients respectively. No clinically adverse events directly related to MVP occurred; in 3 cases device migration was registered without clinical complications. CONCLUSION: MVP is a safe and effective embolic agent. While eventual concomitant anticoagulation therapy did not influence the technical outcome, straight course and length of the landing zone are essential parameters to evaluate before deployment.
format Online
Article
Text
id pubmed-8273051
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82730512021-07-20 Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios Giurazza, Francesco Ierardi, Anna Maria Contegiacomo, Andrea Corvino, Fabio Carrafiello, Giampaolo Niola, Raffaella CVIR Endovasc Original Article AIM: To describe a 3 years experience of peripheral arterial embolization with Micro Vascular Plug (MVP) (Medtronic, USA). MATERIALS AND METHODS: The following parameters were investigated: type of vascular injury, anticoagulation therapy at time of procedure, anatomical district, caliper of the target artery, course of the landing zone, additional embolics, technical and clinical success, device related clinical complications. Technical success was defined as complete embolization without deployment of additional embolics after MVP release. Primary clinical success was considered as hemodynamic stability in emergency setting and resolution of the underlying vascular pathology in elective cases; secondary clinical success was considered clinical success after a second embolization session. RESULTS: 116 MVP have been released in 104 patients (67 males and 37 females; mean age 61.3 years). The pullback release technique was adopted in each case. 85 patients were treated in emergent settings while in 19 patients the procedure was scheduled. The overall technical success was 75%. Primary clinical success was 96.1%, secondary clinical success 3% and clinical failure 0.9%. No statistical differences in terms of effectiveness were observed among patients assuming anticoagulation (p-value = 0.6). A straight and longer landing zone were statistically associated with higher technical success compared to curved and shorter ones, (p-values < 0.001 and = 0.048 respectively). MVP-3 and MVP-5 were the most frequently adopted models in this sample, in 29.8% and 49% of the patients respectively. No clinically adverse events directly related to MVP occurred; in 3 cases device migration was registered without clinical complications. CONCLUSION: MVP is a safe and effective embolic agent. While eventual concomitant anticoagulation therapy did not influence the technical outcome, straight course and length of the landing zone are essential parameters to evaluate before deployment. Springer International Publishing 2021-07-12 /pmc/articles/PMC8273051/ /pubmed/34250548 http://dx.doi.org/10.1186/s42155-021-00246-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Giurazza, Francesco
Ierardi, Anna Maria
Contegiacomo, Andrea
Corvino, Fabio
Carrafiello, Giampaolo
Niola, Raffaella
Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios
title Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios
title_full Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios
title_fullStr Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios
title_full_unstemmed Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios
title_short Embolization with MVP (Micro Vascular Plug(®)): experience on 104 patients in emergent and elective scenarios
title_sort embolization with mvp (micro vascular plug(®)): experience on 104 patients in emergent and elective scenarios
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273051/
https://www.ncbi.nlm.nih.gov/pubmed/34250548
http://dx.doi.org/10.1186/s42155-021-00246-2
work_keys_str_mv AT giurazzafrancesco embolizationwithmvpmicrovascularplugexperienceon104patientsinemergentandelectivescenarios
AT ierardiannamaria embolizationwithmvpmicrovascularplugexperienceon104patientsinemergentandelectivescenarios
AT contegiacomoandrea embolizationwithmvpmicrovascularplugexperienceon104patientsinemergentandelectivescenarios
AT corvinofabio embolizationwithmvpmicrovascularplugexperienceon104patientsinemergentandelectivescenarios
AT carrafiellogiampaolo embolizationwithmvpmicrovascularplugexperienceon104patientsinemergentandelectivescenarios
AT niolaraffaella embolizationwithmvpmicrovascularplugexperienceon104patientsinemergentandelectivescenarios